187 related articles for article (PubMed ID: 35700263)
1. NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression.
Qin Q; Gomez-Salazar M; Tower RJ; Chang L; Morris CD; McCarthy EF; Ting K; Zhang X; James AW
Cancer Res; 2022 Aug; 82(15):2734-2747. PubMed ID: 35700263
[TBL] [Abstract][Full Text] [Related]
2. Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.
Desai J; Shannon ME; Johnson MD; Ruff DW; Hughes LA; Kerley MK; Carpenter DA; Johnson DK; Rinchik EM; Culiat CT
Hum Mol Genet; 2006 Apr; 15(8):1329-41. PubMed ID: 16537572
[TBL] [Abstract][Full Text] [Related]
3. Anoctamin 5 promotes osteosarcoma development by increasing degradation of Nel-like proteins 1 and 2.
Pan R; Lu Q; Ren C; Li H; Zeng F; Tian X; Chen H
Aging (Albany NY); 2021 Jul; 13(13):17316-17327. PubMed ID: 34238763
[TBL] [Abstract][Full Text] [Related]
4. CNTNAP4 signaling regulates osteosarcoma disease progression.
Qin Q; Ramesh S; Gomez-Salazar M; Zhong L; Cherief M; Pratapneni A; Morris CD; McCarthy EF; Zhang X; James AW
NPJ Precis Oncol; 2023 Jan; 7(1):2. PubMed ID: 36599925
[TBL] [Abstract][Full Text] [Related]
5. Efficient production and characterization of recombinant human NELL1 protein in human embryonic kidney 293-F cells.
Hasebe A; Tashima H; Ide T; Iijima M; Yoshimoto N; Ting K; Kuroda S; Niimi T
Mol Biotechnol; 2012 May; 51(1):58-66. PubMed ID: 21814724
[TBL] [Abstract][Full Text] [Related]
6. Oligomerization-induced conformational change in the C-terminal region of Nel-like molecule 1 (NELL1) protein is necessary for the efficient mediation of murine MC3T3-E1 cell adhesion and spreading.
Nakamura Y; Hasebe A; Takahashi K; Iijima M; Yoshimoto N; Maturana AD; Ting K; Kuroda S; Niimi T
J Biol Chem; 2014 Apr; 289(14):9781-94. PubMed ID: 24563467
[TBL] [Abstract][Full Text] [Related]
7. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment.
Liu Y; Ju M; Wang Z; Li J; Shao C; Fu T; Jing Y; Zhao Y; Lv Z; Li G
Biomed Pharmacother; 2020 Aug; 128():110235. PubMed ID: 32454289
[TBL] [Abstract][Full Text] [Related]
8. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.
Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R
Oncogene; 2013 Oct; 32(41):4970-80. PubMed ID: 23222711
[TBL] [Abstract][Full Text] [Related]
9. MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma.
Yang M; Zhang T; Zhang Y; Ma X; Han J; Zeng K; Jiang Y; Wang Z; Wang Z; Xu J; Hua Y; Cai Z; Sun W
J Exp Clin Cancer Res; 2021 May; 40(1):166. PubMed ID: 33980265
[TBL] [Abstract][Full Text] [Related]
10. Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice.
Lin PP; Pandey MK; Jin F; Raymond AK; Akiyama H; Lozano G
Carcinogenesis; 2009 Oct; 30(10):1789-95. PubMed ID: 19635748
[TBL] [Abstract][Full Text] [Related]
11. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
McGary EC; Heimberger A; Mills L; Weber K; Thomas GW; Shtivelband M; Lev DC; Bar-Eli M
Clin Cancer Res; 2003 Dec; 9(17):6560-6. PubMed ID: 14695161
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma.
Nakamura R; Oyama T; Tajiri R; Mizokami A; Namiki M; Nakamoto M; Ooi A
Cancer Sci; 2015 May; 106(5):656-64. PubMed ID: 25726761
[TBL] [Abstract][Full Text] [Related]
13. Human NELL1 protein augments constructive tissue remodeling with biologic scaffolds.
Turner NJ; Londono R; Dearth CL; Culiat CT; Badylak SF
Cells Tissues Organs; 2013; 198(4):249-65. PubMed ID: 24335144
[TBL] [Abstract][Full Text] [Related]
14. The role of extracelluar matrix in osteosarcoma progression and metastasis.
Cui J; Dean D; Hornicek FJ; Chen Z; Duan Z
J Exp Clin Cancer Res; 2020 Sep; 39(1):178. PubMed ID: 32887645
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal region of NELL1 mediates osteoblastic cell adhesion through integrin α3β1.
Hasebe A; Nakamura Y; Tashima H; Takahashi K; Iijima M; Yoshimoto N; Ting K; Kuroda S; Niimi T
FEBS Lett; 2012 Jul; 586(16):2500-6. PubMed ID: 22728432
[TBL] [Abstract][Full Text] [Related]
16. Invasive growth and topoisomerase-switch induced by tumorous extracellular matrix in osteosarcoma cell culture.
Harisi R; Dudás J; Timár F; Pogány G; Timár J; Kovalszky I; Szendroi M; Jeney A
Cell Biol Int; 2005 Nov; 29(11):959-67. PubMed ID: 16242975
[TBL] [Abstract][Full Text] [Related]
17. NELL1 augments osteogenesis and inhibits inflammation of human periodontal ligament stem cells induced by BMP9.
Wang L; Li X; Song Y; Zhang L; Ye L; Zhou X; Song D; Huang D
J Periodontol; 2022 Jul; 93(7):977-987. PubMed ID: 34647317
[TBL] [Abstract][Full Text] [Related]
18. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex.
Zhao SJ; Jiang YQ; Xu NW; Li Q; Zhang Q; Wang SY; Li J; Wang YH; Zhang YL; Jiang SH; Wang YJ; Huang YJ; Zhang XX; Tian GA; Zhang CC; Lv YY; Dai M; Liu F; Zhang R; Zhou D; Zhang ZG
Oncogene; 2018 Feb; 37(8):1049-1061. PubMed ID: 29084211
[TBL] [Abstract][Full Text] [Related]
19. Expression of bone morphogenetic proteins and receptors in sarcomas.
Guo W; Gorlick R; Ladanyi M; Meyers PA; Huvos AG; Bertino JR; Healey JH
Clin Orthop Relat Res; 1999 Aug; (365):175-83. PubMed ID: 10627702
[TBL] [Abstract][Full Text] [Related]
20. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.
Matsumoto Y; Tanaka K; Harimaya K; Nakatani F; Matsuda S; Iwamoto Y
Jpn J Cancer Res; 2001 Apr; 92(4):429-38. PubMed ID: 11346466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
